BEVERLY, Mass., July 14, 2020 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. (TSX.V:LXG)(OTCQB:LXXGF)(FRA: 5XS2)(the “Company”), a molecular diagnostics company that develops genetic analyzers for rapid pathogen detection, is pleased to announce the hiring of its first wave of salespeople to support the commercial launch of MiQLab™ prior to the end of September 2020.
Dr. Jack Regan, LexaGene’s CEO and Founder, states, “To start, we’ve hired a Director of Clinical Sales and a Veterinary Sales Representative. Both have a wealth of experience in their respective fields and will begin working full time for LexaGene. We will continue to hire ...Read The Full Article On StockStreetNews.com
Get early insight on hidden secret gems on StockStreetNews. Follow Crypto, Mining, Cannabis and Energy stocks and get free research reports here.
All content provided by StockStreetNews is subject to our Terms Of Use and Disclaimer.